CEO, Chief Medical Officer and PresidentBleeding & Clotting Disorders Institute, Peoria, IL, USAPeoria, Illinois, United States
PB0238 - Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency During Surgery or Childbirth
Sunday, June 25, 202318:30 – 19:30 ET
PB0987 - Hereditary Antithrombin Deficiency Pilot Project Registry from the American Thrombosis and Hemostasis Network (ATHN)
Monday, June 26, 202318:30 – 19:30 ET
